-
Posted: April 25th, 2012, 8:00am MDT
Conditions: Mucopolysaccharidosis I; Mucopolysaccharidosis VI; Adrenoleukodystrophy; Niemann-Pick Disease; Metachromatic Leukodystrophy; Wolman Disease; Krabbe's Disease; Gaucher's Disease; Fucosidosis; Batten Disease; Severe Aplastic Anemia; Diamond-Blackfan Anemia; Amegakaryocytic Thrombocytopenia; Myelodysplastic Syndrome; Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia
Intervention: Drug: Human Placental Derived Stem Cell
Sponsors: New York Medical College; New York Medical College
Not yet recruiting - verified April 2012
-
Posted: April 12th, 2012, 8:00am MDT
Condition: Cushing's Disease
Intervention: Drug: Pasireotide sub-cutaneous formulation
Sponsors: Novartis; Novartis Pharmaceuticals
Available - verified April 2012
-
Posted: November 15th, 2011, 8:00am MST
Conditions: Cushing's Syndrome; Adrenal Incidentalomas; Alcoholism; Obesity
Intervention:
Sponsors: Haukeland University Hospital; Haukeland University Hospital
Recruiting - verified May 2012
-
Posted: October 14th, 2011, 8:00am MDT
Condition: Smoking Cessation
Interventions: Drug: Placebo; Drug: varenicline tartrate; Drug: bupropion hydrochloride; Drug: Nicotine Replacement Therapy Patch
Sponsors: Pfizer; Pfizer; GlaxoSmithKline
Recruiting - verified May 2012
-
Posted: April 29th, 2010, 8:00am MDT
Conditions: Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
Interventions: Drug: cediranib; Drug: olaparib
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute; Massachusetts General Hospital; Beth Israel Deaconess Medical Center; University of Chicago; National Cancer Institute (NCI)
Recruiting - verified April 2012
-
Posted: April 11th, 2007, 8:00am MDT
Condition: Prostate Cancer
Interventions: Drug: ketoconazole; Drug: lenalidomide; Drug: therapeutic hydrocortisone
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Active, not recruiting - verified May 2012
-
Posted: February 7th, 2005, 8:00am MST
Condition: Prostate Cancer
Interventions: Drug: bicalutamide; Drug: bortezomib; Drug: flutamide; Drug: goserelin acetate; Drug: leuprolide acetate
Sponsors: Medical University of South Carolina; Medical University of South Carolina
Completed - verified April 2012
-
Posted: December 8th, 2004, 8:00am MST
Condition: Prostate Cancer
Interventions: Drug: bicalutamide; Drug: docetaxel; Drug: goserelin acetate; Drug: leuprolide acetate; Procedure: adjuvant therapy; Procedure: neoadjuvant therapy; Radiation: radiation therapy
Sponsors: Medical University of South Carolina; Medical University of South Carolina
Active, not recruiting - verified April 2012